About MiRecule
we develop first-in-class rna-based therapies, with lead programs in head & neck squamous cell carcinoma (hnscc) and facioscalpulohumeral muscular dystrophy (fshd). our approach to d... Read more
we develop first-in-class rna-based therapies, with lead programs in head & neck squamous cell carcinoma (hnscc) and facioscalpulohumeral muscular dystrophy (fshd). our approach to d... Read more